Trials / Recruiting
RecruitingNCT06216496
Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer
Evaluation of Amino Acid Metabolism Changes in Participants With Ovarian Cancer by Dynamic Test
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (estimated)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- Female
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Ovarian cancer is associated with undernutrition in more than half of all cases. The current management of undernutrition-cachexia in cancer is not specific. It is well recognized that the nutritional support currently offered to cancer patients is not effective in combating cachexia, which progresses inexorably, leading to the patient's death. It is therefore necessary to offer specific and adapted care, in particular by optimizing the quality of nitrogen intake. To achieve this, the investigators first need to define the specific amino acid requirements of cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | dynamic test for amino acid metabolism | Subjects are fasting, and the dynamic test is performed as follows: Placement of 1 peripheral venous line (for infusions). * H0-H1.5: infusion of a 10% glucose solution at increasing flow rate (3 steps of 30 min each: 0.06g/kg/h then 0.12g/kg/h then 0.25g/kg/h of glucose) * H1,5: initial blood sampling (amino acid assay) * H1.5-H4.5: infusion of amino acid solution (Aminoven 5%, Fresenius Kabi, Sèvres, France) at constant speed (flow rate 10.5 mg/kg/h of nitrogen or 1.30 ml/kg/H) in Y with glucose infusion (0.25g/kg/h of glucose) * H4.5: Final blood sampling (amino acid assay) Each amino acid is plotted as a function of its perfusion rate on the abscissa and its variation in plasma concentration on the ordinate. |
Timeline
- Start date
- 2024-03-11
- Primary completion
- 2026-04-01
- Completion
- 2026-12-01
- First posted
- 2024-01-22
- Last updated
- 2024-05-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06216496. Inclusion in this directory is not an endorsement.